Charité Universitätsmedizin
Berlin, 13353, Germany
NCT Number: NCT01357707
The project strives to discover novel genetic defects that cause monogenic epilepsy or that genetically modify a preexisting epileptic phenotype. Our main aim is to find genetic causes for the idiopathic West Syndrome (infantile seizures) that are not caused by known cerebral malformation, lissencephaly or metabolic disorders and which have a comparatively benign prognosis.
The investigators hypothesize that mutations in genes coding for ion channels or genes that modify the action of ion channels might be causative.
For that the investigators will perform a sequence analysis of the coding exons of a large set of genes in all recruited patients and verify found mutations in their parents.
Looking for future studies?
Notify Me5 year–10 year
All sexes
Observational
Berlin, 13353, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Taking blood or saliva from the patient to prepare DNA therefrom
Time frame: 4 weeks after taking of the DNA specimen
Markus Schuelke, M.D.
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06714448
Brain Diseases, Central Nervous System Diseases
Chilly-Mazarin, France
View Trial DetailsNCT02886650
Brain Diseases, Central Nervous System Diseases
Paris, France
View Trial DetailsNCT04999046
Brain Diseases, Central Nervous System Diseases
Taipei, Taiwan
View Trial DetailsNCT04770337
Brain Diseases, Central Nervous System Diseases
Phoenix, Arizona, United States
View Trial Details